{"tool_name":"boin","contents":["biotools","bioschemas"],"fetched_metadata":{"biotools":{"id":"boin","home":"https://www.trialdesign.org/","license":"GPL-2.0","summary":"The Bayesian optimal interval (BOIN) design is a novel phase I clinical trial design for finding the maximum tolerated dose (MTD). It can be used to design both single-agent and drug-combination trials.","addition_date":"2022-03-28T14:07:38.798260Z","last_update_date":"2022-03-28T14:07:38.801018Z","tool_type":["Library","Suite","Web application"]},"bioschemas":{"name":"BOIN","home":"https://bio.tools/boin","license":"GPL-2.0","summary":"The Bayesian optimal interval (BOIN) design is a novel phase I clinical trial design for finding the maximum tolerated dose (MTD). It can be used to design both single-agent and drug-combination trials.","tool_type":"sc:SoftwareApplication"}}}